Doctor profile · Federal record

Dr. Manuel Bello Segura, M.D.

Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Endocrinology, Diabetes & Metabolism Physician · Indianapolis, IN

  • NPI 1659774669
  • Accepts Medicare
  • 17 yrs in practice
  • Licensed in 2 states
  • Male
  • Solo practice
  • No sanctions

Practice & contact

Operates at 2 locations .

NPPES Updated May 11, 2026
Primary practice
8435 Clearvista Pl Ste 101
Indianapolis, IN 462563761
(317) 621-1006
Additional location
2500 N State St
Jackson, MS 392164500
(601) 815-2005
fax (601) 815-0434
Mailing address
6626 E 75Th St Ste 500
Indianapolis, IN 462502890

Credentials & registration

NPPES · NUCC
NPI registered
October 2014 — 12 yrs on file
Profile last updated
June 10, 2021
Year of graduation
2009 — 17 yrs since
Specialty taxonomy
207RE0101X — NUCC code
State licenses (2)
Indiana #01084462A · Mississippi #26666

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1659774669. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
2,178
Distinct HCPCS
8
Medicare allowed
$96,278
HCPCS Description Services Patients Avg allowed
J0897 Injection, denosumab, 1 mg 1,500 15 $23
99214 Established patient office or other outpatient visit, 30-39 minutes 385 240 $116
83036 Hemoglobin a1c level 105 78 $9
96372 Injection of drug or substance under skin or into muscle 63 21 $13
99204 New patient office or other outpatient visit, 45-59 minutes 48 48 $155
99213 Established patient office or other outpatient visit, 20-29 minutes 40 39 $84
76536 Ultrasound scan of head and neck soft tissue 25 24 $99
10005 Fine needle aspiration biopsy using ultrasound guidance, first growth 12 12 $126

In context: peer comparison

Among 14 peers in this city , average services per provider: 195. This provider delivers 11× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$3,127
Transactions
144
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Lilly USA, LLC 22 $340.67
Medtronic, Inc. 13 $301.55
Corcept Therapeutics 15 $263.12
Alexion Pharmaceuticals, Inc. 8 $247.24
Amgen Inc. 15 $240.17
Novo Nordisk Inc 13 $211.46
Radius Health, Inc. 13 $208.22
PFIZER INC. 8 $160.91
Novartis Pharmaceuticals Corporation 8 $148.31
Bayer Healthcare Pharmaceuticals Inc. 6 $124.09
Tandem Diabetes Care, Inc. 4 $113.64
ABBVIE INC. 6 $112.14
Insulet Corporation 5 $93.22
Astellas Pharma US Inc 4 $80.61
SANOFI-AVENTIS U.S. LLC 4 $79.96

By nature of payment

Food and Beverage
$3,108
Education
$20

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
2,615
Patients
752
Total drug cost
$1,504,813
Drug Type Claims Patients Total cost
Levothyroxine Sodium Generic 460 130 $7,569
Trulicity (Dulaglutide) Brand 294 68 $452,690
Ozempic (Semaglutide) Brand 249 55 $337,077
Mounjaro (Tirzepatide) Brand 199 58 $248,527
Synthroid (Levothyroxine Sodium) Brand 167 48 $19,252
Metformin Hcl Er (Metformin Hcl) Brand 163 50 $3,082
Farxiga (Dapagliflozin Propanediol) Brand 156 38 $170,194
Pioglitazone Hcl Generic 155 54 $2,324
Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) Brand 150 53 $130,465
Atorvastatin Calcium Generic 130 41 $1,522

Frequently asked questions

Auto-generated from federal data
What is Dr. Manuel Bello Segura's medical specialty?
Dr. Manuel Bello Segura practices Endocrinology, Diabetes & Metabolism Physician in Indianapolis, IN.
Where does Dr. Manuel Bello Segura practice?
Dr. Manuel Bello Segura practices at 8435 Clearvista Pl Ste 101, Indianapolis, IN 462563761. Office phone: 3176211006.
What is Dr. Manuel Bello Segura's NPI?
Dr. Manuel Bello Segura's National Provider Identifier (NPI) is 1659774669, issued by NPPES.
Does Dr. Manuel Bello Segura accept Medicare assignment?
Yes. Dr. Manuel Bello Segura accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Manuel Bello Segura commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Hemoglobin a1c level (HCPCS 83036). Source: CMS Medicare Physician & Other Practitioners file.